Sydney Angels Portfolio Company - Clarity Pharmaceuticals

Clarity is thrilled to announce that the first patient with metastatic prostate cancer to receive 2 doses of 8GBq of Cu-67 SAR-bisPSMA achieves undetectable PSA level. The patient was heavily pre-treated with multiple lines of therapy, including androgen deprivation therapy, ARPI, chemotherapy and a PARP inhibitor and had failed all previous treatments.

Sydney Angels Portfolio Company - Safe-Gauge

As 2023 comes to a close, let's raise a toast to the exceptional journey we've had at SafeGauge. From major expos and prestigious awards to groundbreaking collaborations and product launches, it's been a year filled with achievements and milestones.

None of this would have been possible without your invaluable support. To our incredible customers, partners, and friends, thank you for being a vital part of SafeGauge's success in 2023. Looking forward to reaching new heights together in the coming year.

Sydney Angels Portfolio Company - NOA The Brand

It’s been a big year for us, and no better way to wrap it up than receiving news that NOA The Brand has been accepted into the Startmate Accelerator’s Summer ’24 cohort! 🎉

We are beyond excited to see what the next 12 weeks holds for us and look forward to heading to Melbourne in mid January. Can’t wait to take NOA The Brand to the next level with the Startmate team and their sensational mentor community! 🚀

Until then, we're taking a much needed break and will be back in action in early January. Have a safe and happy holiday break!

Sydney Angels Portfolio Company - Apollo Secure

In a time of increasingly high-profile data breaches and cyber-attacks, Sydney Angels are pleased to announce that one of our most recent portfolio investments, Apollo Secure have completed their pre-seed funding round, raising $600,000 AUD. 24 investors from Sydney Angels have backed Apollo Secure and the syndicate was coordinated by Federico Quaia. Other investors in the round included Brisbane Angels and Angel Loop. Apollo was recently featured in the The Australian Financial Review.

Founded by Damien Cantelo in 2022, Apollo Secure is an automated platform for startups and SMEs to achieve and maintain security compliance. Startups and SMEs have often missed out and fallen behind the curve on data security and compliance, often because of the prohibitive cost of traditional solutions or the lack of knowledge and training required to protect their data and the data of their customers. The Apollo Secure SaaS platform delivers a number of key security features that would otherwise be out of reach for most small businesses. These include a security policies generator, security awareness training, vulnerability scanning, dark web monitoring and a security controls library.

The Sydney Angels team appreciated the team’s ability to put together a simple but effective platform that addresses the needs of an under-served market segment at a time when compliance obligations are increasing. The syndicate expects to see favourable tailwinds for the business in the years ahead.

Congratulations to Damien and the team at Apollo Secure. We look forward to following the team's developments in the months and years ahead.

Sydney Angels Portfolio Company - Edrolo

Congratulations to Sydney Angels portfolio company Edrolo, who have recruited a fantastic new CEO, David Wright after a 12 month search by the founders. David has an excellent track record and commitment to education to help take Edrolo's mission of improving educational outcomes for young people, both in Australia, and abroad, to the next stage. Well done Duncan Anderson, Jeremy Cox and Ben Sze, in getting David to join the team!

Australian Biotec

The Australian pavilion is prominent at #bio2023 - while formal partnering meetings are important and I’ve attended some great educational content, there’s just so much value in hanging out with clients and professional colleagues in an informal setting, and meeting passers-by with an interest in the Australian #biotech industry!

Sydney Angels Portfolio Company - Atomo Diagnostics

Some of our members invested in Atomo right at the beginning in 2010. It's always a pleasure to see how the company has developed and grown over the years. John Kelly, the founder and MD, has tirelessly pursued the vision. Atomo is now poised for broad-based sales growth, with several proven easy-to-use self-test devices being sold in multiple countries, and a pipeline of new devices coming, all based on Atomo's technology platform. We wish everyone at Atomo the best for the future. Thank you!

Sydney Angels Members Meeting at Johnson Winter Slattery

The Sydney Angels Cycle 3 Members Meeting was held last night to an enthusiastic group of members, guests and founders! A special thank you to our friends at Johnson Winter Slattery for hosting this event. We were excited to kick off this cycle face to face, a great evening was had by everyone!

Sydney Angels Portfolio Company Update: Carly Holdings Limited

Congratulations to portfolio company Carly Holdings Limited (ASX:CL8) on the announcement of a $10m asset finance facility to build the fleet of motor vehicles. 4x the size of the owned fleet means lots of revenue growth in the bag and on track towards profitability! Well done to the team.

Sydney Angels Portfolio Company Update: ExtrasJar

The co-founder of Sydney Angels portfolio company ExtrasJar was interviewed by Finder in relation to Private Health Extras cover. Who would have thought the insurance companies don't always help like the could (or should)? Sydney Angels members liked the ExtrasJar concept so much, they invested in it!

Sydney Angels Portfolio Company Update: Carly Holdings Limited

Sydney Angels has been a proud supporter of Carly Holdings Limited (ASX:CL8) from early concepts. Our members are still large supporters & shareholders. Here is an early stage, high growth opportunity in a market leader creating a new category in Australia that everyone can invest in via the ASX. Anyone can be an angel!

Sydney Angels Portfolio Company News: SiteMate

Sydney Angels congratulates the SiteMate team on their latest fund raising, and their continued business growth. Sydney Angels members invested $0.4M in SiteMate in 2017, and followed on each year after that, for a total of $1.2M, plus $0.6M from the Sydney Angels Sidecar Fund over 4 rounds. Blackbird's support for SiteMate's next stage of growth augurs well for the future.

Sydney Angels Portfolio Company News: ExtrasJar

Sydney Angels is very pleased to have backed ExtrasJar (www.extrasjar.com) and is excited to see them launch their evolutionary offering, starting with Pets (and Health coming soon). Traditional Pet Insurance and Health Extras Cover has been poor for consumers (but very profitable for insurers). ExtrasJar is looking to fix that.

Check them out at www.extrasjar.com